The USA-based company’s platform includes a yeast display system, large natural human antibody database, fully human antibody libraries comprised of more than 100 billion antibody clones, flow cytometry-based and other screening technologies, as well as novel methodologies for rabbit monoclonal antibody generation.

AvantGen’s partners include pharmaceutical, biotech, diagnostic and government entities.